X-linked thrombocytopenia in three males with normal sized platelets due to novel WAS gene mutations

Pediatric Blood and Cancer

Volumn 61, Issue 12, 2014, Pages 2305-2306

  Mantadakis, Elpis ^a   Sawalle Belohradsky, Julie ^b   Tzanoudaki, Marianna ^c   Kanariou, Maria ^c   Chatzimichael, Athanassios ^a   Albert, Michael H ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE MEDICAL SCHOOL   (Greece)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Mutations; WAS gene; Wiskott Aldrich syndrome; X linked thrombocytopenia

Indexed keywords

WAS PROTEIN, HUMAN; WISKOTT ALDRICH SYNDROME PROTEIN;

CASE REPORT; CHILD; GENETICS; HUMAN; MALE; MUTATION; PHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; THROMBOCYTE; THROMBOCYTOPENIA; X CHROMOSOME LINKED DISORDER;

BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MUTATION; PROGNOSIS; THROMBOCYTOPENIA; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 84911481654     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25196     Document Type: Article

References (17)

1. Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: A comprehensive review. Ann N Y Acad Sci 2013; 1285:26-43.
2. Ariga T. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features. Allergol Int 2012; 61:183-189.
3. Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: An international collaborative study. Blood 2011; 118:1675-1684.
4. Bosticardo M, Marangoni F, Aiuti A, et al. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 2009; 113:6288-6295.
5. Albert MH, Notarangelo LD, Ochs HD. Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Curr Opin Hematol 2011; 18:42-48.
6. Notarangelo LD, Miao CH, Ochs HD. Wiskott-Aldrich syndrome. Curr Opin Hematol 2008; 15:30-36.
7. Ochs HD, Filipovich AH, Veys P, et al. Wiskott-Aldrich syndrome: Diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant 2009; 15:84-90.
8. Kawai S, Minegishi M, Ohashi Y, et al. Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulations. J Immunol Methods 2002; 260:195-205.
9. Haddad E, Cramer E, Rivière C, et al. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation. Blood 1999; 94:509-518.
10. Corash L, Shafer B, Blaese RM. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood 1985; 65:1439-1443.
11. Patel PD, Samanich JM, Mitchell WB, et al. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size. Pediatr Blood Cancer 2011; 56:1127-1129.
12. Ochs HD, Slichter SJ, Harker LA, et al. The Wiskott-Aldrich syndrome: Studies of lymphocytes, granulocytes, and platelets. Blood 1980; 55:243-252.
13. Mantadakis E, Thomaidis S, Chatzimichael A. Chickenpox-associated immune thrombocytopenic purpura. Hippokratia 2011; 15:190.
14. Albert MH, Bittner TC, Nonoyama S, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: Clinical characteristics, long-term outcome, and treatment options. Blood 2010; 115:3231-3238.
15. Konno A, Wada T, Schurman SH, et al. Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages. Blood 2004; 103:676-678.
16. Imai K, Nonoyama S, Ochs HD. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr Opin Allergy Clin Immunol 2003; 3:427-436.
17. Zhu Q, Watanabe C, Liu T, et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood 1997; 90:2680-2689.